U01.05.022 Sympathomimetics

Learning Objective

By the end of this section, students should be able to classify sympathomimetic drugs, identify their receptor selectivity, predict their hemodynamic effects, and select the appropriate clinical application in common Step 1 scenarios.


Sympathomimetic Drugs

Sympathomimetics are agents that stimulate adrenergic receptors either directly or indirectly, producing cardiovascular, pulmonary, and metabolic effects. Their clinical use depends on receptor selectivity, dose, and route of administration.


Direct Sympathomimetics


β₂-Selective Agonists

Albuterol, Salmeterol, Terbutaline (β₂ > β₁)

  • Hemodynamic effects: Minimal ↑ HR
  • Primary actions: Bronchodilation, uterine relaxation
  • Clinical uses:
    • Albuterol: Acute asthma/COPD exacerbations
    • Salmeterol: Long-term (maintenance) asthma/COPD
    • Terbutaline: Acute bronchospasm, tocolysis


β₁-Selective Agonist

Dobutamine (β₁ > β₂)

  • Hemodynamic effects: ↑ HR, ↑ contractility, ↑ cardiac output; BP unchanged or ↓
  • Clinical uses:
    • Cardiac stress testing
    • Acute decompensated heart failure with cardiogenic shock
  • Key concept: Pure inotrope

Mixed Dopamine Receptor Agonist

Dopamine (D₁ = D₂ > β > α)

  • Dose-dependent effects:
    • Low dose: Renal vasodilation (D₁)
    • Medium dose: ↑ HR, ↑ CO (β₁)
    • High dose: Vasoconstriction, ↑ BP (α₁)
  • Clinical uses: Shock, unstable bradycardia


Mixed α and β Agonists

Epinephrine (β > α)

  • Hemodynamic effects: ↑ HR, ↑ CO; ↑ BP at high doses
  • Clinical uses:
    • Anaphylaxis
    • Asthma
    • Shock
  • Key concept: Stronger β₂ effect than norepinephrine

Norepinephrine (α₁ > α₂ > β₁)

  • Hemodynamic effects: ↑ BP, minimal or reflex ↓ HR, variable CO
  • Clinical uses: Septic shock, severe hypotension


Selective Vasodilators

Fenoldopam (D₁ agonist)

  • Hemodynamic effects: Vasodilation → ↓ BP, ↑ HR, ↑ CO
  • Clinical uses: Hypertensive emergencies
  • Additional effects: Natriuresis
  • Adverse effects: Headache, flushing, hypotension

Pure β Agonist

Isoproterenol (β₁ = β₂)

  • Hemodynamic effects: ↓ BP (vasodilation), ↑ HR, ↑ CO
  • Clinical uses: Electrophysiologic testing for arrhythmias
  • Note: No α activity → may worsen ischemia

α₁-Selective Agonists

Phenylephrine (α₁ > α₂)

  • Hemodynamic effects: ↑ BP, reflex ↓ HR, ↓ or unchanged CO
  • Clinical uses:
    • Hypotension
    • Nasal decongestion
    • Mydriasis
    • Ischemic priapism

Midodrine (α₁)

  • Hemodynamic effects: ↑ BP, ↓ HR
  • Clinical uses: Orthostatic hypotension
  • Caution: Supine hypertension

β₃-Selective Agonist

Mirabegron (β₃)

  • Primary effect: Bladder relaxation
  • Clinical use: Overactive bladder
  • Mnemonic: “Mirab3gron”

Indirect Sympathomimetics


These agents increase endogenous catecholamines by promoting release or inhibiting reuptake.

Amphetamine

  • Mechanism: Increases release + inhibits reuptake of catecholamines
  • Clinical uses: ADHD, narcolepsy, obesity

Cocaine

  • Mechanism: Reuptake inhibition of NE, dopamine, serotonin
  • Effects: Vasoconstriction, local anesthesia
  • Key warning: Avoid β-blockers → unopposed α₁ stimulation
  • Special use: Produces mydriasis in intact sympathetic innervation (Horner syndrome testing)

Ephedrine / Pseudoephedrine

  • Mechanism: Releases stored catecholamines
  • Clinical uses:
    • Nasal decongestion
    • Hypotension
    • Urinary incontinence

Activity


Discover more from mymedschool.org

Subscribe to get the latest posts sent to your email.